Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
LeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsPreferred Shares Issued
Ratios

vTv Therapeutics (VTVT) Accumulated Depreciation & Amortization (2016 - 2024)

vTv Therapeutics' Accumulated Depreciation & Amortization history spans 11 years, with the latest figure at $508000.0 for Q4 2024.

  • For Q4 2024, Accumulated Depreciation & Amortization rose 4.31% year-over-year to $508000.0; the TTM value through Dec 2024 reached $508000.0, up 4.31%, while the annual FY2024 figure was $508000.0, 4.31% up from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2024 was $508000.0 at vTv Therapeutics, up from $487000.0 in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $508000.0 in Q4 2024 and bottomed at $216000.0 in Q4 2020.
  • The 5-year median for Accumulated Depreciation & Amortization is $397000.0 (2022), against an average of $382600.0.
  • The largest annual shift saw Accumulated Depreciation & Amortization soared 45.95% in 2020 before it increased 4.31% in 2024.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $216000.0 in 2020, then surged by 41.2% to $305000.0 in 2021, then surged by 30.16% to $397000.0 in 2022, then increased by 22.67% to $487000.0 in 2023, then grew by 4.31% to $508000.0 in 2024.
  • Per Business Quant, the three most recent readings for VTVT's Accumulated Depreciation & Amortization are $508000.0 (Q4 2024), $487000.0 (Q4 2023), and $397000.0 (Q4 2022).